PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro.
about
Role of retinoids in the prevention and treatment of colorectal cancerThe potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signallingInverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasionAnticancer activities of pterostilbene-isothiocyanate conjugate in breast cancer cells: involvement of PPARγ15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone lossRosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancerAll-trans retinoic acid (ATRA) downregulates MMP-9 by modulating its regulatory moleculesModulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapyProvitamin A carotenoids are independently associated with matrix metalloproteinase-9 in plasma samples from a general population.Cohort study of pioglitazone and cancer incidence in patients with diabetesCytotoxic Activities against Breast Cancer Cells of Local Justicia gendarussa Crude Extracts.Amplified inhibition of stellate cell activation pathways by PPAR-γ, RAR and RXR agonistsExpression of tissue inhibitor of matrix metalloproteinases-1 during aging in rat liver.PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling.PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in?All-trans-retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells: ROLE OF NOTCH1 AND TRANSFORMING GROWTH FACTOR (TGFβ).Retinoic acid reduces migration of human breast cancer cells: role of retinoic acid receptor betaModification of MCF-10A cells with pioglitazone and serum-rich growth medium increases soluble factors in the conditioned medium, likely reducing BT-474 cell growth.Peroxisome proliferator-activated receptor-gamma ligands for the treatment of breast cancer.PPARγ agonists target aromatase via both PGE2 and BRCA1.Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells.MiRNA-10b sponge: An anti-breast cancer study in vitro.Peroxisome proliferator-activated receptors and progression of colorectal cancer.Pretreatment of BMSCs with TZD solution decreases the proliferation rate of MCF‑7 cells by reducing FGF4 protein expression.PPAR Ligands as Potential Modifiers of Breast Carcinoma Outcomes.Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells.Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer.Integrative analysis of mutational and transcriptional profiles reveals driver mutations of metastatic breast cancers.PPAR Gamma Activators: Off-Target Against Glioma Cell Migration and Brain Invasion.Hepatic vitamin A preloading reduces colorectal cancer metastatic multiplicity in a mouse xenograft model.PPARγ maintains ERBB2-positive breast cancer stem cells.All-trans retinoic acid protects against doxorubicin-induced cardiotoxicity by activating the ERK2 signalling pathwayA gene expression signature identifies two prognostic subgroups of basal breast cancer.Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression.Phosphatidylinositol 3-kinase mediates the ability of retinol to decrease colorectal cancer cell invasion.The Roles of Dietary PPARgamma Ligands for Metastasis in Colorectal Cancer.A clinically relevant bi-cellular murine mammary tumor model as a useful tool for evaluating the effect of retinoic acid signaling on tumor progression.Anti-invasive effect of gambogic acid in MDA-MB-231 human breast carcinoma cells.
P2860
Q26781463-E87844C1-6065-4025-AC74-022D91ADBDC3Q28087571-348DC57A-E1AD-4E2D-82ED-3DBD46B03307Q28280615-9B651631-83B0-4DCE-B60E-6DD6218A7BDFQ28541836-C4E1DC27-B920-4049-9CE1-E101BFDAFFA7Q28546055-FCAC8B4D-5405-4B6B-8CB9-C7D183100330Q33318963-C6D09E0E-BBFE-4955-A98F-3099F5EEA13EQ33396559-A95672C3-401F-46B7-9DC1-01532927C50FQ34219471-2EBD8B4F-3F5B-4109-B8F1-4A6488A49F39Q34237948-413A25D6-E969-44A1-8BB8-EAB6AAB53476Q34637321-444806A8-D33E-429A-874F-C8696851CD34Q34718437-C3037E60-A12B-4D90-9174-8D6F1F244163Q34773801-B7BAACD6-3D7A-470D-B5BF-7D0F4D9919FCQ35009520-48A6A945-F27A-420E-AF5B-5D030ADDBC97Q35045455-C6594DDE-125D-4ABC-8AC4-744D59B8634FQ35458969-7894C6DC-7AE3-4571-9D67-51478C76C463Q35608757-0039A9C1-A008-4A3B-8697-4ED4EAD6F006Q35680221-A1924B10-E0B9-46A8-AFB0-8CE2EFA40DF6Q35859452-FC6503D3-22CC-4D1F-A6A5-47ADA0E1C378Q35867945-E55E4C0A-D8C5-4879-8395-73B72D716A55Q36057300-E134E37D-49E7-44A5-A46E-2EA6F0C8BEBEQ36187022-A9B81AC1-6936-4DCE-B20A-E89F5146A015Q36303977-186EBA78-B652-41A8-BEA4-94F2C2B86524Q36611745-AD703E30-6C42-4954-9061-D35A603B0E25Q36640939-2C463AB6-9897-4044-81D2-CA3DAAB2FD36Q36710291-B468C8C4-6DB3-43C7-B377-A9AB0E2373CBQ36722145-59C3F6B6-4181-40B6-8B71-C2E341F1BE14Q36772391-DA53FE34-A5BA-46EB-BD83-F32B9EBC4AC3Q37038408-8B3F3394-325A-47C9-8023-AF22300187ECQ37157524-29098E42-37EB-457B-8C89-6AE4F7D115AAQ37215939-B7A1B638-A01E-4C1A-9768-E9510145DE91Q37278858-8D34D36F-EF92-4748-9110-0CD0BDACF0F8Q37313157-7E4D8FE2-A48D-4FFC-BF12-6ACED44EBE30Q37501777-4DF7156A-B179-4B79-95C3-570944DB0C6DQ37686126-E4FD0DA8-E8D1-46ED-A692-DCFED52D8E92Q38506362-316357AB-F4F5-4083-B88B-7E78934A4362Q38828335-ED672FA0-D0AE-4469-977E-6011140F7ABFQ38943885-C3A6EB4B-8976-4022-A219-ADF28CC3A518Q39019899-DAD01386-EC5E-4FE7-8F7A-C9815C1948F2Q39388529-8B1ED4F1-C4B0-4CDA-8407-A740343DC647Q39928765-B7D5919F-0997-4851-86E8-0E2CBE60F20E
P2860
PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro.
@en
type
label
PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro.
@en
prefLabel
PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro.
@en
P2093
P2860
P356
P1476
PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro.
@en
P2093
P2860
P2888
P356
10.1023/A:1023366117157
P407
P577
2003-05-01T00:00:00Z
P6179
1017706445